DOCSLIB.ORG

Open Full Page

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Open Full Page [CANCER RESEARCH 61, 2307–2310, March 1, 2001] Distribution and Functional Consequences of Nucleotide Polymorphisms in the 3؅-Untranslated Region of the Human Sep15 Gene1 Ya Jun Hu, Konstantin V. Korotkov, Rajeshwari Mehta, Dolph L. Hatfield, Charles N. Rotimi, Amy Luke, T. Elaine Prewitt, Richard S. Cooper, Wendy Stock, Everett E. Vokes, M. Eileen Dolan, Vadim N. Gladyshev,2 and Alan M. Diamond2 Departments of Human Nutrition and Dietetics [Y. J. H., A. M. D.], Surgical Oncology [R. M.], and Hematology/Oncology [W. S.], University of Illinois at Chicago, Chicago, Illinois 60612; Department of Biochemistry, University of Nebraska, The Beadle Center, Lincoln, Nebraska 68588 [K. V. K., V. N. G.]; Section on the Molecular Biology of Selenium, Basic Research Laboratory, National Cancer Institute, NIH, Bethesda, Maryland 20892 [D. L. H.]; Department of Genetic Epidemiology, National Human Genome Center, Howard University, Washington DC 20059 [C. N. R.]; Department of Preventive Medicine and Epidemiology, Loyola University, Stritch School of Medicine, Maywood, Illinois 60153 [A. L., T. E. P., R. S. C.]; and Department of Medicine [E. E. V., M. E. D.], University of Chicago, Chicago, Illinois 60637 ABSTRACT translation requires a recognition element within the 3Ј-UTR3 (3) of the corresponding mRNA referred to as a SECIS element (7). SECIS ele- Selenium has been shown to prevent cancer in a variety of animal ments are present in the mRNAs of all of the selenocysteine-containing model systems. Both epidemiological studies and supplementation trials proteins and share structural features, including an approximately 80- have supported its efficacy in humans. However, the mechanism by which nucleotide stem-loop structure containing both an internal and apical loop selenium suppresses tumor development remains unknown. Selenium is of unpaired nucleotides and a conserved 4-bp domain within the stem. present in known human selenoproteins as the amino acid selenocysteine Although the functions of several selenoproteins have been determined, (Sec). Sec is inserted cotranslationally in response to UGA codons within to date there has not been definitive evidence associating any of these -selenoprotein mRNAs in a process requiring a sequence within the 3؅ untranslated region (UTR), referred to as a Sec insertion sequence (SE- proteins with either cancer risk or development. A recent search for novel selenium-containing proteins resulted in the isolation and characterization CIS) element. Recently, a human Mr 15,000 selenoprotein (Sep15) was identified that contains an in-frame UGA codon and a SECIS element in of a new selenoprotein (8). Examination of data contained in the dbEST the 3؅-UTR. Examination of the available cDNA sequences for this protein databases resulted in the assembly of a 1268 nucleotide cDNA with an revealed two polymorphisms located at position 811 (C/T) and at position ORF of 162 amino acids. Within this ORF was an in-frame UGA codon G/A) located within the 3؅-UTR. Here, we demonstrate significant corresponding to amino acid 93. This and the observation that this protein) 1125 75 differences in Sep15 allele frequencies by ethnicity and that the identity of labels with Se and contains a SECIS element in the 3Ј-UTR strongly the nucleotides at the polymorphic sites influences SECIS function in a support the conclusion that the Mr 15,000 selenoprotein (Sep15) contains selenium-dependent manner. This, together with genetic data indicating selenocysteine at position 93. Further analysis of the Sep15 cDNA loss of heterozygosity at the Sep15 locus in certain human tumor types, sequence indicated that it was well conserved through evolution; homol- suggests that Sep15 may be involved in cancer development, risk, or both. ogous genes exist in mouse, rat, Brugia malayi, Caenorhabditis elegans, and other animals. On the basis of the frequency of recovery of Sep15 cDNA sequences from particular libraries included in the dbEST data- INTRODUCTION base, it was concluded that Sep15 is expressed in a wide variety of human tissues, with the highest levels being observed in the thyroid and prostate Selenium is an essential trace element currently being considered as a (8, 9). Examination of the available cDNA sequences for this protein candidate chemopreventive agent. Research spanning the last 25 years revealed two distinct forms of the Sep15 gene differing by polymor- has established that selenium is effective in the reduction of cancer phisms located at position 811 (C/T) and at position 1125 (G/A) within incidence when provided to animals as doses only 5- to 10-fold above the the 3Ј-UTR (8). Here, we demonstrate significant differences in Sep15 nutritional requirement (1). Chemoprevention studies with selenium in allele frequencies by ethnicity and that the identity of the nucleotides at animal model systems have indicated that this element is effective for the polymorphic sites influences SECIS function in a selenium-dependent most, if not all of the organ systems and is protective against the manner. This, together with genetic data indicating LOH at the Sep15 carcinogenic effects of a wide variety of insults (1). Both epidemiological locus in certain human tumor types, suggests that Sep15 may be involved studies and supplementation trials have also supported its efficacy in in cancer etiology. humans (2–5). However, the mechanism by which selenium suppresses tumor development remains unknown. Many of the biological activities MATERIALS AND METHODS of selenium are attributable to its role as a constituent of selenium- containing proteins. In all of the known mammalian selenoproteins, Sample Sources. The majority of the samples obtained from African Amer- selenium exists as the amino acid selenocysteine, which is inserted icans, 490 subjects, was recruited from the community of Maywood, IL, a suburb of Chicago. Unrelated individuals over the age of 18 years were identified through cotranslationally into the nascent protein in response to the UGA codon door-to-door canvassing and asked to participate in a study of diet and heart in selenoprotein mRNA (6). In mammals, the molecular choice to insert disease from an IRB-approved protocol, and signed consent was given from all of selenocysteine into the elongating selenoprotein rather than terminate the individuals. Exclusion criteria included any known cancer, non-insulin-depen- dent diabetes mellitus, and heart disease. The lymphocytes from normal volunteers Received 8/30/00; accepted 12/28/00. and colon tumor samples were collected anonymously from an IRB-approved The costs of publication of this article were defrayed in part by the payment of page protocol. All subjects were Ͼ18 years of age. Normal Caucasian volunteers were charges. This article must therefore be hereby marked advertisement in accordance with recruited from the University of Chicago. Colon tumor samples were obtained 18 U.S.C. Section 1734 solely to indicate this fact. 1 Supported in part by a grant from the American Institute for Cancer Research (to after surgical resection from patients with confirmed colon cancer. African- A. M. D.), a grant from the Cancer Research Foundation of America (to V. N. G.), and American patients with hematological malignancies were treated according to National Institute of Dental Research/National Cancer Institute Grant 11921 (to E. E. V.). institutional IRB-approved treatment studies for acute myeloid leukemia, acute 2 To whom requests for reprints should be addressed, Alan M. Diamond, Department of Human Nutrition and Dietetics, University of Illinois at Chicago, Chicago, IL 60612. Fax: (312) 413-0319; E-mail: adiamond@uic.edu; or Vadim N. Gladyshev, Department of 3 The abbreviations used are: UTR, untranslated region; Sec, selenocysteine; SECIS, Biochemistry, University of Nebraska, The Beadle Center, Lincoln, NE 68588. Fax: selenocysteine insertion sequence; LOH, loss of heterozygosity; ORF, open reading (402) 472-4948; E-mail: vgladyshev1@unl.edu. frame; IRB, Institutional Review Board; EST, expressed sequence tag. 2307 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2001 American Association for Cancer Research. DISTRIBUTION AND FUNCTION OF Sep15 POLYMORPHISMS lymphoblastic leukemia, and chronic myeloid leukemia. All subjects were Ͼ18 for either SpeIorPstI(5Ј-AAAACTAGTGCTTTGTAACAGACTTGCG- years of age, were referred to the University of Illinois at Chicago for treatment, GTTAATTATGC-3Ј or 5Ј-AAAGTGCAGGGTCTTACAAATGATCACT- and consented to an IRB-approved study for the analysis of molecular abnormal- TTTAAATGGAC-3Ј, respectively). Amplification was as described above, ities present in leukemia cells. Bone marrow and blood samples were obtained at and the products were digested with SpeI and PstI and directionally cloned into specified time points before, during, and after completion of treatment. Breast the pBPLUGA plasmid. Transfection of mouse NIH 3T3 cells was performed carcinomas from African-American women were archived from the Department of using the lipofectin reagent at a ratio of 1:3 (v/v) as indicated by the vendor Surgical Oncology Tissue and Sera Bank at the University of Illinois at Chicago. (Life Technologies, Inc.). The cells were cotransfected with the reporter Originally, tumors were obtained from women with confirmed histopathological construct and the pSV2Neo plasmid at a 10:1 molar ratio, and transfectants diagnosis of breast cancer who were undergoing lumpectomy or mastectomy. were selected with the antibiotic geneticin G418. G418-resistant
Load more

Recommended publications
  • Identification and Characterization of a Selenoprotein Family Containing a Diselenide Bond in a Redox Motif
    Identification and characterization of a selenoprotein family containing a diselenide bond in a redox motif Valentina A. Shchedrina, Sergey V. Novoselov, Mikalai Yu. Malinouski, and Vadim N. Gladyshev* Department of Biochemistry, University of Nebraska, Lincoln, NE 68588-0664 Edited by Arne Holmgren, Karolinska Institute, Stockholm, Sweden, and accepted by the Editorial Board July 13, 2007 (received for review April 16, 2007) Selenocysteine (Sec, U) insertion into proteins is directed by trans- notable exception. Vertebrate selenoprotein P (SelP) has 10–18 lational recoding of specific UGA codons located upstream of a Sec, whose insertion is governed by two SECIS elements (11). It is stem-loop structure known as Sec insertion sequence (SECIS) ele- thought that Sec residues in SelP (perhaps with the exception of the ment. Selenoproteins with known functions are oxidoreductases N-terminal Sec residue present in a UxxC motif) have no redox or containing a single redox-active Sec in their active sites. In this other catalytic functions. work, we identified a family of selenoproteins, designated SelL, Selenoproteins with known functions are oxidoreductases con- containing two Sec separated by two other residues to form a taining catalytic redox-active Sec (12). Their Cys mutants are UxxU motif. SelL proteins show an unusual occurrence, being typically 100–1,000 times less active (13). Although there are many present in diverse aquatic organisms, including fish, invertebrates, known selenoproteins, proteins containing diselenide bonds have and marine bacteria. Both eukaryotic and bacterial SelL genes use not been described. Theoretically, such proteins could exist, but the single SECIS elements for insertion of two Sec.
    [Show full text]
  • Composition and Evolution of the Vertebrate and Mammalian Selenoproteomes
    Composition and Evolution of the Vertebrate and Mammalian Selenoproteomes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Mariotti, Marco, Perry G. Ridge, Yan Zhang, Alexei V. Lobanov, Thomas H. Pringle, Roderic Guigo, Dolph L. Hatfield, and Vadim N. Gladyshev. 2012. Composition and evolution of the vertebrate and mammalian selenoproteomes. PLoS ONE 7(3): e33066. Published Version doi:10.1371/journal.pone.0033066 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10341925 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Composition and Evolution of the Vertebrate and Mammalian Selenoproteomes Marco Mariotti1,2., Perry G. Ridge3., Yan Zhang1,4., Alexei V. Lobanov1, Thomas H. Pringle5, Roderic Guigo2, Dolph L. Hatfield6, Vadim N. Gladyshev1* 1 Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, 2 Center for Genomic Regulation and Universitat Pompeu Fabra, Barcelona, Spain, 3 Department of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, Nebraska, United States of America, 4 Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China, 5 Sperling Foundation, Eugene, Oregon, United States of America, 6 Laboratory of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America Abstract Background: Selenium is an essential trace element in mammals due to its presence in proteins in the form of selenocysteine (Sec).
    [Show full text]
  • Selenocysteine, Pyrrolysine, and the Unique Energy Metabolism of Methanogenic Archaea
    Hindawi Publishing Corporation Archaea Volume 2010, Article ID 453642, 14 pages doi:10.1155/2010/453642 Review Article Selenocysteine, Pyrrolysine, and the Unique Energy Metabolism of Methanogenic Archaea Michael Rother1 and Joseph A. Krzycki2 1 Institut fur¨ Molekulare Biowissenschaften, Molekulare Mikrobiologie & Bioenergetik, Johann Wolfgang Goethe-Universitat,¨ Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany 2 Department of Microbiology, The Ohio State University, 376 Biological Sciences Building 484 West 12th Avenue Columbus, OH 43210-1292, USA Correspondence should be addressed to Michael Rother, m.rother@bio.uni-frankfurt.de andJosephA.Krzycki,krzycki1@osu.edu Received 15 June 2010; Accepted 13 July 2010 Academic Editor: Jerry Eichler Copyright © 2010 M. Rother and J. A. Krzycki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Methanogenic archaea are a group of strictly anaerobic microorganisms characterized by their strict dependence on the process of methanogenesis for energy conservation. Among the archaea, they are also the only known group synthesizing proteins containing selenocysteine or pyrrolysine. All but one of the known archaeal pyrrolysine-containing and all but two of the confirmed archaeal selenocysteine-containing protein are involved in methanogenesis. Synthesis of these proteins proceeds through suppression of translational stop codons but otherwise the two systems are fundamentally different. This paper highlights these differences and summarizes the recent developments in selenocysteine- and pyrrolysine-related research on archaea and aims to put this knowledge into the context of their unique energy metabolism. 1. Introduction found to correspond to pyrrolysine in the crystal structure [9, 10] and have its own tRNA [11].
    [Show full text]
  • Identification and Characterization of Fep15, a New Selenocysteine-Containing Member of the Sep15 Protein Family
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Vadim Gladyshev Publications Biochemistry, Department of March 2006 Identification and characterization of Fep15, a new selenocysteine-containing member of the Sep15 protein family Sergey V. Novoselov University of Nebraska-Lincoln Deame Hua University of Nebraska-Lincoln A. V. Lobanov University of Nebraska-Lincoln Vadim N. Gladyshev University of Nebraska-Lincoln, vgladyshev@rics.bwh.harvard.edu Follow this and additional works at: https://digitalcommons.unl.edu/biochemgladyshev Part of the Biochemistry, Biophysics, and Structural Biology Commons Novoselov, Sergey V.; Hua, Deame; Lobanov, A. V.; and Gladyshev, Vadim N., "Identification and characterization of Fep15, a new selenocysteine-containing member of the Sep15 protein family" (2006). Vadim Gladyshev Publications. 62. https://digitalcommons.unl.edu/biochemgladyshev/62 This Article is brought to you for free and open access by the Biochemistry, Department of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Vadim Gladyshev Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Published in Biochemical Journal 394:3 (March 15, 2006), pp. 575–579. doi: 10.1042/BJ20051569. Copyright © 2005 The Biochemical Society, London. Used by permission. Submitted September 22, 2005; revised October 18, 2005; accepted and prepublished online October 20, 2005; published online February 24, 2006. Identifi cation and characterization of Fep15, a new selenocysteine-containing member of the Sep15 protein family Sergey V. Novoselov, Deame Hua, Alexey V. Lobanov, and Vadim N. Gladyshev* Department of Biochemistry, University of Nebraska–Lincoln, Lincoln, NE 68588 *Corresponding author; email: vgladyshev1@unl.edu Abstract: Sec (selenocysteine) is a rare amino acid in proteins.
    [Show full text]
  • Focus on the Small Heat Shock Protein HSPB1 Autofagie in De Erfelij
    Faculteit Faculteit Farmaceutische, Biomedische en Diergeneeskundige wetenschappen Biochemie en Biotechnologie Autophagy in inherited peripheral neuropathies: Focus on the small heat shock protein HSPB1 Autofagie in de erfelijke perifere neuropathieën: Focus op de kleine heat shock proteïne HSPB1 Proefschrift voorgelegd tot het behalen van de graad van Doctor in de Wetenschappen: Biochemie en Biotechnologie aan de Universiteit Antwerpen. te verdedigen door Mansour HAIDAR Promotor Prof. Dr. Vincent Timmerman Antwerpen, 2018 1 2 “Haud igitur redit ad Nihilum res ulla, sed omnes Discidio redeunt in corpora materiai” Lucretius, De Rerum Natura, Book I. 250 3 4 Members of the jury Chair Prof. Dr. Wim Vanden Berghe, PhD (UA, Antwerp, Belgium) Promotor Prof. Dr. Vincent Timmerman, PhD (UA, Antwerp, Belgium) Internal jury member Prof. Dr. Wim Martinet, PhD (UA, Antwerp, Belgium) External jury members Prof. Dr. Joy Irobi (UHasselt, Hasselt, Belgium) Prof. Dr. Maurizio D’Antonio (San Raffaele Institute, Milan, Italy) Prof. Dr. Ir. Winnok De Vos (UA, Antwerp, Belgium) 5 6 Table of Contents Summary/Samenvatting 9 Rationale and Aims 13 Introduction Chapter 1 Autophagy as an emerging common pathomechanism in inherited 15 peripheral neuropathies Chapter 2 Small heat shock proteins: Their role in proteostasis 79 and neurodegeneration Results Chapter 3 HSPB1 is required for Autophagy: Insights from CMT-causing mutations 103 Chapter 4 An interactomics study of HSPB1 wild-type and mutant links it to the 129 autophagy receptor P62 Discussion 179 List of abbreviations 195 Curriculum Vitae 199 Acknowledgements 203 7 8 Summary Inherited peripheral neuropathies (IPNs) are genetically heterogeneous disorders affecting mainly the peripheral nervous system and with over 1500 mutations in more than 80 affected genes discovered so far.
    [Show full text]
  • Deficiency in the 15-Kda Selenoprotein Inhibits Tumorigenicity and Metastasis of Colon Cancer Cells
    Published OnlineFirst April 13, 2010; DOI: 10.1158/1940-6207.CAPR-10-0003 Published Online First on April 13, 2010 as 10.1158/1940-6207.CAPR-10-0003 Research Article Cancer Prevention Research Deficiency in the 15-kDa Selenoprotein Inhibits Tumorigenicity and Metastasis of Colon Cancer Cells Robert Irons1,3,4, Petra A. Tsuji1,2,3, Bradley A. Carlson3, Ping Ouyang1,3, Min-Hyuk Yoo3, Xue-Ming Xu3, Dolph L. Hatfield3, Vadim N. Gladyshev5, and Cindy D. Davis1 Abstract Selenium has cancer-preventive activity that is mediated, in part, through selenoproteins. The role of the 15-kDa selenoprotein (Sep15) in colon cancer was assessed by preparing and using mouse colon CT26 cells stably transfected with short hairpin RNA constructs targeting Sep15. Metabolic 75Se labeling and Northern and Western blot analyses revealed that >90% of Sep15 was downregulated. Growth of the resulting Sep15-deficient CT26 cells was reduced (P < 0.01), and cells formed significantly (P < 0.001) fewer colonies in soft agar compared with control CT26 cells. Whereas most (14 of 15) BALB/c mice injected with control cells developed tumors, few (3 of 30) mice injected with Sep15-deficient cells developed tumors (P < 0.0001). The ability to form pulmonary metastases had similar results. Mice injected with the plasmid-transfected control cells had >250 lung metastases per mouse; however, mice injected with cells with downregulation of Sep15 only had 7.8 ± 5.4 metastases. To investigate molecular targets affected by Sep15 status, gene expression patterns between control and knockdown CT26 cells were compared. Ingenuity Pathways Analysis was used to analyze the 1,045 genes that were significantly (P < 0.001) affected by Sep15 deficiency.
    [Show full text]
  • A Large Prospective Study of SEP15 Genetic Variation, Interaction with Plasma Selenium Levels, and Prostate Cancer Risk and Survival
    A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Penney, K. L., F. R. Schumacher, H. Li, P. Kraft, J. S. Morris, T. Kurth, L. A. Mucci, et al. 2010. “A Large Prospective Study of SEP15 Genetic Variation, Interaction with Plasma Selenium Levels, and Prostate Cancer Risk and Survival.” Cancer Prevention Research 3 (5): 604– 10. https://doi.org/10.1158/1940-6207.capr-09-0216. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:41292599 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA NIH Public Access Author Manuscript Cancer Prev Res (Phila). Author manuscript; available in PMC 2011 May 1. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Cancer Prev Res (Phila). 2010 May ; 3(5): 604±610. doi:10.1158/1940-6207.CAPR-09-0216. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival Kathryn L. Penney1,2, Fredrick R. Schumacher3, Haojie Li4, Peter Kraft1, J. Steven Morris5, Tobias Kurth1,6, Lorelei A. Mucci1,2, David J. Hunter1,2, Philip W. Kantoff7, Meir J. Stampfer1,2, and Jing
    [Show full text]
  • Original Article Selenoproteins Translated by SECIS-Deficient Mrna Induce Apoptosis in Hela Cells
    Int J Clin Exp Med 2018;11(10):10881-10888 www.ijcem.com /ISSN:1940-5901/IJCEM0081467 Original Article Selenoproteins translated by SECIS-deficient mRNA induce apoptosis in Hela cells Lifang Tian1, Fumeng Huang1, Li Wang1, Zhao Chen1, Jin Han1, Dongmin Li2, Shemin Lu2, Rongguo Fu1 1Department of Nephrology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China; 2Department of Genetics and Molecular Biology in College of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, China Received June 19, 2018; Accepted September 6, 2018; Epub October 15, 2018; Published October 30, 2018 Abstract: Objective: The aim of this study was to explore the biological function of selenoproteins translated by SECIS-deficient mRNAs of selenoprotein S (SelS), glutathione peroxidase 4 (Gpx4), and thioredoxin reductase 1 (TrxR1). Methods: Recombinant plasmids of normal and selenocysteine insertion sequence (SECIS)-deficient mRNAs of SelS, Gpx4, and TrxR1 were constructed and transfected into Hela cells. Total RNA was collected by TRIzol method and cDNA were obtained by mRNA reverse transcription. To ensure that target selenoprotein genes were successfully transfected into cells and highly expressed, PCR was performed for only 15 circulations. Bright bands were then observed of target genes. Results: After transfection for 24 hours, expression of green fluorescent protein was noted and the transfection efficiency was detected up to 40% by fluorescein activated cell sorter analysis. After transfection for 48 hours, cells were collected to stain for fluorescein activated cell sorter analysis. Results showed that Hela cell apoptosis could be induced by selenoproteins translated by SECIS-deficient mRNAs but not normal selenoproteins.
    [Show full text]
  • A Regulatory Role for Sec Trna in Selenoprotein Synthesis
    Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press A regulatory role for Sec tRNA[Ser]Sec in selenoprotein synthesis RUTH R. JAMESON and ALAN M. DIAMOND Department of Human Nutrition, University of Illinois at Chicago, Chicago, Illinois 60612, USA ABSTRACT Selenium is biologically active through the functions of selenoproteins that contain the amino acid selenocysteine. This amino acid is translated in response to in-frame UGA codons in mRNAs that include a SECIS element in its 3؅ untranslated region, and this process requires a unique tRNA, referred to as tRNA[Ser]Sec. The translation of UGA as selenocysteine, rather than its use as a termination signal, is a candidate restriction point for the regulation of selenoprotein synthesis by selenium. A specialized reporter construct was used that permits the evaluation of SECIS-directed UGA translation to examine mechanisms of the regulation of selenoprotein translation. Using SECIS elements from five different selenoprotein mRNAs, UGA translation was quantified in response to selenium supplementation and alterations in tRNA[Ser]Sec levels and isoform distributions. Although each of the evaluated SECIS elements exhibited differences in their baseline activities, each was stimulated to a similar extent by increased selenium or tRNA[Ser]Sec levels and was inhibited by diminished levels of the methylated isoform of tRNA[Ser]Sec achieved using a dominant-negative acting mutant tRNA[Ser]Sec. tRNA[Ser]Sec was found to be limiting for UGA translation under conditions of high selenoprotein mRNA in both a transient reporter assay and in cells with elevated GPx-1 mRNA.
    [Show full text]
  • <I>AUREOCOCCUS ANOPHAGEFFERENS</I>
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2016 MOLECULAR AND ECOLOGICAL ASPECTS OF THE INTERACTIONS BETWEEN AUREOCOCCUS ANOPHAGEFFERENS AND ITS GIANT VIRUS Mohammad Moniruzzaman University of Tennessee, Knoxville, mmoniruz@vols.utk.edu Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Environmental Microbiology and Microbial Ecology Commons Recommended Citation Moniruzzaman, Mohammad, "MOLECULAR AND ECOLOGICAL ASPECTS OF THE INTERACTIONS BETWEEN AUREOCOCCUS ANOPHAGEFFERENS AND ITS GIANT VIRUS. " PhD diss., University of Tennessee, 2016. https://trace.tennessee.edu/utk_graddiss/4152 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu. To the Graduate Council: I am submitting herewith a dissertation written by Mohammad Moniruzzaman entitled "MOLECULAR AND ECOLOGICAL ASPECTS OF THE INTERACTIONS BETWEEN AUREOCOCCUS ANOPHAGEFFERENS AND ITS GIANT VIRUS." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Microbiology. Steven W. Wilhelm, Major Professor We have read this dissertation
    [Show full text]
  • On the Road to Selenocysteine
    COMMENTARY On the road to selenocysteine Alan M. Diamond* Department of Human Nutrition, University of Illinois, Chicago, IL 60612 ecades ago, a mammalian purified PSTK established the substrate enzymes with antioxidant capabilities tRNA that exclusively bound specificity of this enzyme exclusively for (glutathione peroxidases) and those the UGA stop codon was both seryl-tRNA[Ser]Sec isoforms, which involved with the maintenance of the identified by using the triplet differ by only a single modified base (5). reduced cellular environment (thiore- Dbinding assay that was instrumental in It is highly significant that the initial doxin reductases) and the maturation deciphering the genetic code (1). The method of detection, a computer- of thyroxin (thyroid hormone deiodi- possibility of a naturally occurring sup- assisted analysis of genomes that were nases). Other mammalian selenopro- pressor tRNA presented the dilemma known either to contain or to be miss- teins of known function include SelP, of explaining the biological function of ing the selenoprotein synthesis machin- which is involved with selenium trans- such a molecule. In the same year, an ery, was successful at all. The presence port; SPS2, which is required for Sec equally perplexing report indicated the of PSTK in archaeal and eukaryote ge- synthesis; and SelR, a methionine sul- existence of tRNA from either rooster nomes that were known to translation- foxide reductase (reviewed in ref. 12). or rat liver that was aminoacylated ally synthesize selenoproteins, but its Although the biochemical properties with phosphoserine (2). That observa- absence in the genomes of organisms (i.e., cellular location and binding part- tion was verified several years later that do not, is consistent with the role ners) are known for several other sel- when phosphoseryl tRNA was also of PSTK indicated by Carlson et al.
    [Show full text]
  • Thyroxine Binding to Type III Iodothyronine Deiodinase Craig A
    www.nature.com/scientificreports OPEN Thyroxine binding to type III iodothyronine deiodinase Craig A. Bayse*, Eric S. Marsan, Jenna R. Garcia & Alexis T. Tran‑Thompson Iodothyronine deiodinases (Dios) are important selenoproteins that control the concentration of the active thyroid hormone (TH) triiodothyronine through regioselective deiodination. The X‑ray structure of a truncated monomer of Type III Dio (Dio3), which deiodinates TH inner rings through a selenocysteine (Sec) residue, revealed a thioredoxin-fold catalytic domain supplemented with an unstructured Ω-loop. Loop dynamics are driven by interactions of the conserved Trp207 with solvent in multi-microsecond molecular dynamics simulations of the Dio3 thioredoxin(Trx)-fold domain. Hydrogen bonding interactions of Glu200 with residues conserved across the Dio family anchor the loop’s n‑terminus to the active site Ser‑cys-Thr‑Sec sequence. A key long‑lived loop conformation coincides with the opening of a cryptic pocket that accommodates thyroxine (T4) through an I⋯Se halogen bond to Sec170 and the amino acid group with a polar cleft. The Dio3-T4 complex is stabilized by an I⋯O halogen bond between an outer ring iodine and Asp211, consistent with Dio3 selectivity for inner ring deiodination. Non-conservation of residues, such as Asp211, in other Dio types in the fexible portion of the loop sequence suggests a mechanism for regioselectivity through Dio type- specifc loop conformations. Cys168 is proposed to attack the selenenyl iodide intermediate to regenerate Dio3 based upon structural comparison with related Trx-fold proteins. Iodothyronine deiodinase (Dio) membrane selenoproteins regulate thyroid hormone (TH) activity through regioselective deiodination (Fig. 1a)1–10.
    [Show full text]